Assessments of outcome in haemophilia – what is the added value of QoL tools?. (2nd June 2015)

• Record Type: Journal Article
• Authors: van den Berg, H. M.; Feldman, B. M.; Fischer, K.; Blanchette, V.; Poonnoose, P.; Srivastava, A.
• Is Part Of: Haemophilia. Volume 21:Number 4(2015:Jul.)
• Page Start: 430
• Page End: 435
• Publication Date: 2015-06-02
• Subjects: Hemophilia -- Periodicals; 616.1572005
• DOI: 10.1111/hae.12731
• Languages: English
• ISSNs: 1351-8216

Abstract

<abstract abstract-type="main" id="hae12731-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="hae12731-sec-0001" sec-type="section"> <title>Introduction</title> <p>Access to treatment and especially to long‐term regular replacement treatment with clotting factor concentrates (prophylaxis) have caused dramatic contrasts in the clinical picture between haemophilia populations. An individual patient with severe haemophilia age 20 years can have normal joints or can be severely crippled and unable to work. Assessment of outcome in a standardized way has therefore become essential.</p> </sec> <sec id="hae12731-sec-0002" sec-type="section"> <title>Aim</title> <p>Discuss the relevance and utility of the different outcome assessment tools in patient groups with different access to treatment.</p> </sec> <sec id="hae12731-sec-0003" sec-type="section"> <title>Methods</title> <p>In the last decade new outcome assessment tools specific for haemophilia have been developed that measure all aspects of health according to the International Classification of Functioning, Disability and Health (ICF) model. These tools are directed at assessing the clinical and radiological status of joints as well as overall functioning, such as participation and psychosocial aspects, evaluating overall health‐related quality of life (HRQOL). For deciding which tools to use in clinical practice or research, one needs to consider the specific context with regard to disease burden, healthcare environment and socioeconomic background of the patients being evaluated.</p> </sec> <sec id="hae12731-sec-0004" sec-type="section"> <title>Conclusion</title> <p>Prospective systematic assessment of outcome in haemophilia and related bleeding disorders is important. Based upon recent literature a critical appraisal of outcome tools is described.</p> </sec> </abstract>